News
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational ...
One of Mission’s largest employers announced mass layoffs in the company, citing financial concerns and a “challenging environment.” ...
Rep. Preston Stinson (R-Edmond) and Sen. Brent Howard (R-Altus) released a joint statement following Governor Kevin Stitt’s ...
New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...
Decades into its tenure as a drug seller, CSL Behring has finally dipped its toe into the waters of TV advertising. | Decades ...
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...
California's AB 824 law has important implications for branded and generics companies involved in settlement agreements. AB ...
Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.
BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results